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Ciliary biology
Motile cilia (flagella) arose in the eukaryotic lineage in 
single-celled protists, where they took on signaling capa-
ci ties, and it was only with the emergence of the multi-
cellular animal kingdom that their non-motile cousins 
(primary cilia) appeared. Motile cilia in multi-ciliated 
organisms beat in coordinated waves and are found in 
various tissues, where they perform a variety of functions. 
For example, motile cilia in the trachea function in 
sweeping mucus and particulates out of the lungs and in 
the fallopian tubes they assist in moving the ovum from 
the fallopian tube to the uterus. Primary cilia, on the 
other hand, have a role in sensory detection. In worms, 
for example, they are present exclusively in a handful of 
neurons used to detect food. Although there are some 
cells with motile and primary cilia in vertebrates, most 
cells have primary cilia whereas only a handful of cells 
have motile cilia. Both types of cilia have a protruding 
microtubule structure called the axoneme emerging from 
a basal body that contains the pair of centrioles (Figure 1). 
Structurally, the axonemes in both motile and primary 
cilia comprise nine doublet microtubules, but primary 
cilia differ in that they lack the two central microtubules 
(9 + 0) that motile cilia have (9 + 2).
Cilia maintain separate cytoplasmic and membrane 
compartments, but are completely lacking vesicles. Instead 
cilia rely on specialized modes of transportation called 
intraflagellar transport (IFT) to deliver cargo proteins and 
lipids along the axoneme. IFT can operate in the 
anterograde direction (towards the ciliary tip) using 
complex B factors, or in the retrograde direction (towards 
the ciliary base) using complex A factors; together these 
factors regulate the transport speed and net cargo flux. An 
important, recently emerged aspect of cilia is the 
gatekeeper role of the septin family of proteins, regulating 
initial entry and exit of ciliary factors at the base of the 
cilium [1]. The transition zone, where the gatekeeper 
functions, is an adjacent structure at the base of the cilium, 
forming the linkers between microtubule and ciliary 
membrane; it is probably required for unload ing ciliary-
directed cargo and sorting ciliary-based signal ing 
mechanisms [2] so that the cell can interpret their context.
Emerging genetics of the ciliopathies
Although ciliopathies are individually rare disorders, an 
amazing spectrum of what were previously disparate 
syndromes is now recognized as part of the ciliopathy 
spectrum. Ciliopathies can be subdivided into ‘motile 
ciliopathies’ and ‘non-motile ciliopathies’, although we 
usually define ciliopathies as disorders that result from 
aplasia and/or disrupted function of primary cilia. Motile 
ciliopathies comprise a class of disorders displaying 
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‘Ciliopathies’ are an emerging class of genetic 
multisystemic human disorders that are caused by a 
multitude of largely unrelated genes that affect ciliary 
structure/function. They are unified by shared clinical 
features, such as mental retardation, cystic kidney, 
retinal defects and polydactyly, and by the common 
localization of the protein products of these genes at 
or near the primary cilium of cells. With the realization 
that many previously disparate conditions are a part of 
this spectrum of disorders, there has been tremendous 
interest in the function of cilia in developmental 
signaling and homeostasis. Ciliopathies are mostly 
inherited as simple recessive traits, but phenotypic 
expressivity is under the control of numerous genetic 
modifiers, putting these conditions at the interface 
of simple and complex genetics. In this review, we 
discuss the ever-expanding ciliopathy field, which has 
three interrelated goals: developing a comprehensive 
understanding of genes mutated in the ciliopathies 
and required for ciliogenesis; understanding how the 
encoded proteins work together in complexes and 
networks to modulate activity and structure-function 
relationships; and uncovering signaling pathways and 
modifier relationships.
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pro mi nent situs inversus (a condition in which the 
normal positions of organs are reversed). Non-motile 
ciliopathies show prominent but mixed features in 
several vital organs, including the brain, kidney and liver, 
and others, such as the eye and digit. Ciliopathies range 
from largely organ-specific disorders, such as polycystic 
kidney disease (PKD), to pleiotropic disorders, such as 
cerebello-oculo-renal syndrome (CORS), Bardet-Biedl 
syndrome (BBS), Jeune asphyxiating thoracic dystrophy 
(JATD) and Meckel-Gruber syndrome (MKS) (Figure 2). 
All cilio pathies known so far show a recessive mode of 
inheri tance, either autosomal or X-linked, with strong 
evidence of genetic modifiers that determine expressivity. 
More over, clinically distinguishable ciliopathies often 
result from mutations in a single gene (Table 1), suggest-
ing complex genetic networks.
Figure 1. Schematic of a primary (non-motile) cilium and intraflagellar transport (IFT). (a) Ciliary cargo proteins, transported from the Golgi 
network to the basal body, move between the base and the tip of the cilium by IFT. Motor proteins, such as kinesin 2 and dynein 2, associated with 
IFT complexes, are responsible for movement along axonemal microtubules in an anterograde and retrograde direction, respectively. (b) Schematic 
diagram of axoneme cross-section. Motile cilia have a 9 + 2 microtubule pair ultrastructure, with inner and outer dynein arms, whereas primary cilia 
typically have 9 + 0 arrangement, without dynein arms.
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Although the disease-specific function of any single 
mutated gene in a particular ciliopathy has not yet been 
understood, the identification of several causative genes 
has contributed to a better understanding of the patho-
genesis of the disorders and the biological functions of 
cilia over the past two decades. In the attempt to identify 
candidate genes, diverse high-throughput tech niques 
have been applied, such as in silico comparative genomics, 
transcriptome analysis including analysis of X-box 
promoters, which are involved in the regulation of ciliary 
genes in Caenorhabditis elegans, and proteomics. These 
complementary approaches led to the identifi cation of 
several new disease-causative ciliary genes and also 
propelled the ciliary biology field from basic science into 
the biomedical realm.
Here, we summarize the clinical and genetic features of 
each ciliopathy disorder and outline the expanding range 
of a systems-biology approach applied to the study of 
ciliopathies. We also discuss advantages of the new 
genomic approaches and future strategies that will assist 
the transfer of research achievements into clinical practice.
Genes required for ciliary-mediated signaling and ciliary 
function
What are the roles of primary cilia and how were these 
roles missed for so long? The primary cilia that were 
evident from detailed electron microscopic studies over 
40 years ago were initially considered to be evolutionary 
remnants without specific function. The first few genes 
identified from positional cloning of human and mouse 
Figure 2. Almost every organ in the body shows vulnerability in the ciliopathies. Most ciliopathies have overlapping clinical features in 
multiple organs. Cystic kidney and retinal defects are frequently observed. Skeletal dysplasia is predominantly seen in JATD, OFD1 and EVC. ALMS, 
Alström syndrome; BBS, Bardet-Biedl syndrome; CORS, cerebello-oculo-renal syndrome; EVC, Ellis-van Creveld syndrome; JATD, Jeune asphyxiating 
thoracic dystrophy; JBTS, Joubert syndrome; LCA, Leber congenital amaurosis; MKS, Meckel syndrome; NPHP, nephronophthisis; OFD1, oral-facial-
digital syndrome type 1; PCD, primary ciliary dyskinesia; PKD, polycystic kidney disease.
Hydrocephalus: 
PCD, OFD1
Retinal defect/degeneration: 
PCD, BBS, MKS, NPHP, 
JBTS, ALMS, LCA, CORS Mental retardation: 
BBS, NPHP, JBTS, CORS
Cystic kidneys:
PKD, JATD, OFD1, BBS, 
MKS, NPHP, JBTS, ALMS,
CORS
Craniofacial defect:
OFD1
Cardiac defect: 
PCD, EVC, BBS, MKS,
NPHP, ALMS
Liver cysts:
MKS, NPHP, JBTS,
ALMS, CORS
Lung or airway defect:
PCD, BBS, MKS, NPHP
Rib/thoracic skeleton defect:
JATD, EVC
Pelvic bone defect:
JATD
Polydactyly:
JATD, OFD1, 
EVC, BBS, JBTS
Sterility or genital defect:
PCD, BBS, MKS, JBTS
Pancreatic cysts:
NPHP
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Table 1. Ciliopathies, genes and subcellular functions of the proteins
Disorders Symptoms Inheritance Causative genes Putative protein functions
Primary ciliary 
dyskinesia (PCD)/
Kartagener 
syndrome (KS)
Chronic sinusitis, 
bronchiectasis and infertility 
with situs inversus (KS 
only) and occasional 
hydrocephalus (PCD)
Autosomal 
recessive
DNAH5 Cilia motility
DNAH11 Cilia motility
DNAl1 Cilia motility
DNAl2 Cilia motility
TXNDC3 Unknown
KTU Dynein arm preassembly, Cilia motility
RSPH9 Central pair/motility
RSPH4A Central pair/motility
LRRC50 Cilia motility
Leber congenital 
amaurosis (LCA)
Retinal dystrophy, blindness 
or severe visual impairment 
such as sensory nystagmus, 
amaurotic pupils and 
absent electroretinogram 
signal
Autosomal 
recessive
CEP290;NPHP6* RPGR complex, trafficking
LCA5 RPGR complex, trafficking
TULP1 Rhodopsin trafficking
RPGRIP1 RPGR complex
Polycystic kidney 
disease (PKD): 
dominant (ADPKD), 
recessive (ARPKD)
Hepatic cysts, pancreatic 
cysts (10%), cysts in the 
nephron (ADPKD only) and 
hepatic fibrosis, cysts in 
collecting ducts (ARPKD 
only)
Autosomal 
dominant, 
Autosomal 
recessive
PKD1 Mechanosensation, cell-cell or cell-matrix interactions
PKD2 Probable calcium channel protein
PKHD1 Probable receptor protein, PC2 modulation
Jeune asphyxiating 
thoracic dystrophy 
(JATD)
Postaxial polydactyly, short 
limbs, short and slender 
ribs, small ilia, irregular 
acetabulum and cystic 
kidney
Autosomal 
recessive
ATD1 Role in Shh signaling
Ellis-van Creveld 
syndrome (EVC)
Polydactyly, short ribs, 
dysplastic fingernails/teeth 
and cardiac defects
Autosomal 
recessive
EVC1 Unknown
EVC2 Unknown
Oral-facial-digital 
syndrome type I 
(OFD1)
Craniofacial malformations, 
postaxial polydactyly, 
central nervous system 
defects and cystic kidney 
(~15%)
X-linked  
dominant
OFD1* Ciliogenesis, Wnt/PCP signaling, association with LCA5 and 
SDCCAG8
Nephronophthisis 
(NPHP)
Triad of tubular basement 
membrane disruption, 
tubulointerstitial 
nephropathy, 
corticomedullary cysts. 
Pancreatic/hepatic fibrosis, 
situs inversus, retinitis 
pigmentosa, cerebellar 
vermis hypoplasia, 
oculomotor apraxia and 
mental retardation (~10%)
Autosomal 
recessive 
NPHP1 * Cilia structure, cell-cell adhesion
NPHP2;INVS Wnt/PCP, cell cycle control
NPHP3 Wnt/PCP pathway
NPHP4 Cilia structure, IFT
NPHP5;IQCB1 RPGR/Calmodulin complex
NPHP6;CEP290* RPGR complex, trafficking
NPHP7;CLIS2 Transcription factor, Wnt
NPHP8;RPGRIP1L* Shh signaling
NPHP9;NEK8 Modulation of PC1 and PC2
NPHP10;SDCCAG8 Association with OFD1
NPHP11;TMEM67* Ciliogenesis
NPHPL1;XPNPEP3 Unknown
Joubert syndrome 
(JBTS)/JBTS-related 
disorder (JSRD)
Hypotonia, ataxia, 
psychomotor delay, 
oculomotor apraxia, 
retinal degeneration 
and mental retardation. 
Occipital encephalocele, 
polymicrogyria, cystic 
kidney, hepatic fibrosis and 
polydactyly (JSRD)
Autosomal 
recessive
JBTS1;INPP5E Cilia stability, phosphatidylinositol signaling
JBTS2;TMEM216* Ciliogenesis, centrosomal docking, PCP signaling
JBTS3;AHI1 Wnt signaling
JBTS4;NPHP1* Cilia structure, cell-cell adhesion
JBTS5;CEP290* RPGR complex, trafficking
JBTS6;TMEM67* Ciliogenesis
JBTS7;RPGRIP1L* Shh signaling
JBTS8;ARL13B Cilia structure, IFT
JBTS9;CC2D2A* Association with CEP290
JBTS10;OFD1* Ciliogenesis, Wnt/PCP, association with LCA5 and SDCCAG8
JBTS11;TTC21B Ciliogenesis
JBTS12;KIF7 Shh signaling, microtubule dynamics
JBTS13;TCTN1 Transition zone complex regulation
Continued overleaf
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disease genes did not point to the cilium as the site of 
their action. It was not until the accumulation of evidence 
suggesting the localization of the encoded proteins at or 
near the cilium that the importance of the primary cilium 
was realized, and the field of ciliopathies was born [3-5]. 
The simplistic idea that these genes were required merely 
for assembly of a cilium was rapidly usurped by obser-
vations of defective signaling in specific pathways at the 
cilium, most notably the Sonic hedgehog (Shh), canonical 
and non-canonical Wnt, and platelet derived growth 
factor (PDGF) pathways (Figure 3). There are probably a 
wealth of other yet unexplored pathways that are modu-
lated by the primary cilium, which cells seem to use to 
concentrate signals or to help convey the spatial and 
temporal context in which to interpret extracellular 
signals.
Genes required for ciliary structure or motility
Formation of ciliary axonemal structures, such as the 
dynein arms, radial spokes, central pair of microtubules 
and central sheath, is necessary for regulating motility 
and beating of the cilia (Figure 1). Patients with primary 
ciliary dyskinesia or Kartagener syndrome (PCD/KS) can 
show ultrastructural axonemal defects in motile cilia [6]. 
In addition, it is not surprising that many genes, such as 
DNAH5, DNAI1, DNAI2, DNAH1, KTU, RSPH9, RSPH4A 
and LRRC50, encoding proteins associated with ciliary 
axonemal architecture or entry of these factors into cilia, 
have been found to be mutated in PCD/KS [7-11].
Interestingly, a few genes mutated in the non-motile 
ciliopathies also seem to be linked with structural 
formation of the axoneme. For example, mutations of 
ARL13B in mouse Joubert syndrome (JBTS) and NPHP4 
in C. elegans nephronophthisis (NPHP) give rise to ultra-
structural defects of the ciliary axoneme, although the 
defects are relatively subtle [12,13]. Patients with BBS 
have defects in the axoneme of spermatozoon flagella, 
which are closely related to cilia, and correspondingly 
Bbs2 knockout mice have abnormal spermatozoon 
flagellum formation [14]. The connection between ciliary 
structure and function remains a central focus of the field.
Advanced high-throughput strategies in the study 
of ciliopathies
Using traditional approaches of human genetics, such as 
positional cloning, meiotic mapping, physical mapping 
and candidate-gene sequencing [15], PKD1 in PKD [16] 
and NPHP1 in NPHP [17] were identified as initial causa-
tive genes of ciliopathies in the late 1990s. Further diverse 
approaches, including promoter analysis, comparative 
genomics, transcriptome analysis and proteomics, have 
resulted in the identification of numerous ciliary-related 
Table 1. Ciliopathies, genes and subcellular functions of the proteins
Disorders Symptoms Inheritance Causative genes Putative protein functions
Bardet-Biedl 
syndrome (BBS)
Obesity, diabetes, 
polydactyly, mental 
retardation, cystic kidney, 
retinitis pigmentosa, 
hypogenitalism and situs 
inversus
Autosomal 
recessive
BBS1 BBSome, Wnt/PCP, IFT/trafficking
BBS2 BBSome, IFT/trafficking
BBS3;ARL6 Vesicle trafficking
BBS4 BBSome, IFT/trafficking, microtubule anchoring, cell cycle 
control
BBS5 BBSome, IFT/trafficking, ciliogenesis
BBS6;MKKS IFT/trafficking, Wnt/PCP, cytokinesis, chaperonin
BBS7 BBSome, IFT/trafficking
BBS8;TTC8 BBSome, IFT/trafficking
BBS9;PTHB1 BBSome
BBS10 Ciliogenesis, Wnt, chaperonin
BBS11;TRIM32 E3 ubiquitin-protein ligase
BBS12 Ciliogenesis, Wnt, chaperonin
Alström syndrome 
(ALMS)
Cone-rod retinal 
dystrophy, hearing defects, 
cardiomyopathy, early-
onset obesity, renal failure 
and hepatic dysfunction
Autosomal 
recessive
ALMS1 Cilia maintenance
Meckel-Gruber 
syndrome (MKS)
Renal cysts, hepatic fibrosis, 
central nervous system 
malformations, polydactyly, 
liver malformations, 
laterality defects, cardiac 
defects
Autosomal 
recessive 
MKS1 Ciliogenesis
MKS2;TMEM216* Ciliogenesis, centrosomal docking, PCP signaling
MKS3;TMEM67* Ciliogenesis
MKS4;CEP290* RPGR complex, trafficking
MKS5;RPGRIP1L* Shh signaling
MKS6;CC2D2A* Association with CEP290
Disorders are described in the order of increasing phenotypic severity. Asterisks indicate genes causing allelic disorders. Semicolons indicate two different names of 
the same gene. RPGR, retinitis pigmentosa GTPase regulator.
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genes and causative disease genes underlying ciliopathies 
[18,19]. These new technologies gave new insights into 
understanding pathogenesis of the disorders and ciliary 
biology.
Proteomics
Following the identification of many causative genes 
underlying specific classes of ciliopathies, it was observed 
that the proteins from a given class of ciliopathies tend to 
assemble with reproducible stoichiometry. This was first 
demonstrated for the complex of proteins encoded by 
genes mutated in BBS (called the BBSome), and has since 
extended to proteins from other ciliopathies, including 
those in the NPHP-JBTS-MKS complex [20,21]. The core 
of each complex is made up of the proteins identified from 
humans with similar disease. For example, the BBSome is 
constituted by tight interactions between 7 of 12 BBS 
proteins. The NPHP-JBTS-MKS complex contains non-
overlapping components, mostly proteins previously 
implicated in NPHP, JBTS and MKS, but also some 
unexpected proteins such as ATXN10 and TCTN2, both 
of which were subsequently found to be mutated in NPHP 
and JBTS, suggesting the likely relevance of the complex.
The BBSome and the NPHP-JBTS-MKS complex are 
present in the ciliary region in the absence of ciliary 
disease. However, the function of these complexes in 
ciliary biology (and ciliary disease) is still not clear, 
although evidence suggests that the BBSome functions as 
a vesicular coat that transports membrane proteins to the 
cilia [22]. There is mounting evidence that the NPHP-
JBTS-MKS complex, with an estimated molecular weight 
between 0.7 and 2 MDa, functions at or near the 
transition zone of the primary cilia and regulates ciliary 
entry/localization of many proteins [23]. It remains to be 
determined whether other multigenic ciliopathy disorders 
similarly display non-overlapping components and how 
such complexes function at or near the cilium.
Thus, it is informative to consider these as disease-
specific protein complexes, constituted by a host of non-
redundant factors, each of which serves a still poorly 
defined function. Work in C. elegans suggests that the 
MKS and NPHP proteins establish basal body/transition 
zone membrane attachments coincident with IFT-
dependent axoneme extension. In this light, it is perhaps 
not surprising that genetic evidence obtained by crossing 
mutants in C. elegans demonstrates more severe syn-
thetic phenotypes (functional interactions) only when 
mutations occur in two different disease modules [2]. For 
instance, the B9 domain proteins of the MKS module 
functionally interact with the NPHP module [24] but not 
with most other proteins in the MKS module. We can 
conclude that each protein complex probably forms an 
intricate modular network, as evidenced by specificity in 
the protein complexes and by functional redundancy.
Figure 3. Various signaling pathways modulated by the 
primary cilium. (a) Platelet-derived growth factor (PDGF) signaling 
through PDGF receptor αα requires ciliary localization of the 
receptor to activate downstream targets mediated by the MAP 
kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) 
pathway. (b) Canonical Wnt signaling through LRP5/6 and Frizzled 
(Fzd) is probably inhibited by the primary cilium, whereas the 
planar cell polarity (PCP) non-canonical pathway requires factors 
essential for ciliogenesis for activity, probably by mediating cellular 
polarity and polarized basal body localization, and is then activated 
by Dishevelled (Dvl) interacting with either Fzd or other PCP 
components. (c) Binding of Shh to patched 1 (Ptc1) activates Shh 
signaling by releasing inhibition of smoothened (Smo)-Gli-mediated 
downstream target gene transcription.
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Application of next-generation sequencing
The ciliary biology field has greatly benefited from the 
tremendous gains in proteomics and genomics through 
the definition of the concept of the ‘ciliome’. The ciliome 
consists almost completely of genes implicated in ciliary 
function, on the basis of a compilation of results from 
various studies involving human genetics, functional 
genetics and proteomics, and it is currently made up of 
more than 2,500 human orthologs. As expected, many of 
the genes subsequently identified as mutated in cilio-
pathies were already part of this compiled list, which has 
led to more efficient workflow by focusing on these 
genes. By applying next-generation sequencing (NGS) 
with a focus on the ciliome, new human disease genes 
have recently been identified in a relatively short time 
[25] and much larger groups of patients can be screened 
for existing genes, greatly aiding future genotype-pheno-
type correlations [26,27]. The phenotypic variability often 
shown among ciliopathy patients carrying the same 
combinations of mutations has suggested the presence of 
modifier genes and/or the involvement of tri-allelic 
inheritance [28-32]. NGS potentially allows sequencing 
of an entire human genome in a few days and outputs 
thousands of new variants in candidate genes. In addi-
tion, a recent study, combining a massive number of in 
vivo experiments [32], has tested the possibility that new 
deleterious variants of known causative genes may func-
tion as modifiers in ciliopathies.
NGS approaches are greatly broadening the sophisti ca-
tion and types of today’s experiments in the ciliopathy 
field, as is occurring in other fields, using genome-wide 
approaches. By targeting human families with key cilio-
pathy features, and applying either homo zygosity mapping 
or whole exome sequencing approaches to identify causa-
tive genes, several diseases that were pre viously not con-
sidered as ciliopathies, such as Jeune syndrome [33], acro-
callosal syndrome [34] and cranio ectodermal dysplasia 
[35-37], are now considered to be in the extended ciliopathy 
spectrum. Interestingly, not all genes encoding centro-
somal or pericentrosomal proteins cause ciliopathies, as 
the recent examples involving Seckel syndrome (primordial 
dwarfism) have shown [38,39]. We thus conclude that 
there must be specificity of function in these centrosomal 
proteins, some function ing in cell cycle regulation or DNA 
repair and others in ciliary regulation, even if these func-
tions are not as well delineated in non-human species [40].
Application of high-throughput genomics
Cell-based screens using high-throughput functional 
analysis offer an exciting opportunity to identify key 
regulators of cellular structure and function. Application 
of genetic, chemical or even genome-wide small inter-
fering RNA libraries to ciliated cells followed by 
assessment of signaling or ciliary structure provides an 
important complementary approach to understanding 
ciliary-specific genetic requirements [41-44]. These 
cellular analyses have uncovered many important signal-
ing mechanisms, some of which are pharmacologically 
tractable and may serve as a basis for the development of 
future therapy, in particular because the assays can be 
targeted to bypass specific patient-related cellular defects. 
For instance, we found that positive regulators of actin 
polymerization functioned as negative regulators of cilio-
genesis [44], and vice versa, prompting us to question 
whether actin destabilizers might promote ciliogenesis in 
cellular models of disease. We found that low dose appli-
cation of the actin polymerization inhibitor cyto chalasin 
D partially rescued cilum elongation defects caused by 
the hypomorphic mouse mutation Ift88 [41-44]. Further 
genomic screening focusing on a specific cellular process, 
such as ciliation linked to cell cycle regulation, post-
translational modification of microtubules and regulation 
of ciliary transport and signaling, will lead to a greater 
understanding of ciliary structure/function relationships, 
their relevance to disease and potential treatments.
Future prospects
The broad range of clinical features observed in cilio-
pathies leads us to ask how defects caused in a small 
cellular organelle give rise to such diverse clinical features 
in multiple organs. Identification and functional investi-
gation of causative genes have always been emphasized 
and the recent accessibility of high-throughput NGS has 
propelled the ciliary biology field from basic science into 
the biomedical realm. The main challenge of NGS, 
however, lies in interpreting the massive amount of 
resulting data. The thousands of novel mutations found 
in every exome must be sorted by thorough filtering of 
the variants to determine which one is causative. Careful 
selection of patients with highly similar clinical features 
increases the likelihood of finding many different 
mutations in the same genes and the ability to distinguish 
pathogenic from benign variants.
As ciliopathies are rare, complex, multi-symptom 
diseases, treatment to ameliorate the symptoms and 
provide better (prenatal) diagnosis will be more feasible 
than targeted therapies. For instance, kidney failure is the 
most widespread symptom among several ciliopathies. It 
therefore may be possible that candidate drugs used to 
treat kidney disease, such as polycystic kidney disease 
(PKD), can be used in ciliopathy patients to help alleviate 
kidney symptoms. With rapidly dropping costs of NGS 
and more sophisticated advances in bioinformatics, it 
may be possible to use genomics to stratify patients for 
optimal prescribing and/or treatment in the near future. 
Personalized medicine developed through comprehensive 
data obtained by complementary approaches may be the 
best hope for patients with ciliopathies.
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